Cite

    Scailteux, L. et al. (2016). Mortality, cardiovascular risk, and androgen deprivation therapy for prostate cancer: A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies. Medicine. 95 (24), pp. e3873-. [Online].